Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.

As we head into the New Year, experts across the tech landscape weigh in to share what they think will happen in 2026 ...

In a world that often celebrates “day”, “arrival” and the “result” — the signed treaty, the product launch, the graduation ...

High-resolution 3D womb model gives insights into embryo implantation, infertility, and signals between embryo and mother, ...

Scientists have recreated the human womb lining in the lab, revealing how embryos implant and survive after fertilisation, ...

Cases of consumer AI bias have attracted widespread attention, highlighting the challenges of ensuring fairness in automated systems. Google Gemini, for instance, faced criticism for generating ...

Steven SukkauLocal Journalism Initiative ReporterWinnipeg Sun Manitoba Hydro is signalling a significant shift in how the ...

ValOre Metals Corp. (“ValOre” or “the Company”; TSX-V: VO, OTCQB: KVLQF, Frankfurt: KEQ0) today announced the appointment of engineering company LYCOPODIUM ...

Starting an AI journey can seem daunting. Major investments in AI continue to stem from mega-corporations that are either ...

The transaction builds on an established partnership between the EBRD and BOSQAR, which has resulted in up to €150 million in equity and bond financing to date. More broadly, the EBRD has invested ...

New method ASPEN accurately maps gene activity from each parent in individual cells, overcoming noise in data. It revealed ...

Organoid Intelligence (OI) represents a groundbreaking convergence of biology and technology, aiming to redefine biocomputing using brain organoids—three-dimensional neural structures derived from ...